CRNX
Crinetics Pharmaceuticals Inc.
$44.43
-$0.50(-1.11%)
65
Overall
--
Value
75
Tech
55
Quality
Market Cap
$4.00B
Volume
1.70M
52W Range
$24.10 - $62.53
Target Price
$79.19
Key Metrics Overview
| Market Cap | $4.00B | P/E Ratio | N/A |
| 52W High | $62.53 | 52W Low | $24.10 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | -9.6% | 52W Position | 52.9% |
| Overall Score | 65 | Value Score | -- |
| Quality Score | 55 | Technical Score | 75 |
Growth Analysis
| EPS Current Est | $-4.84 | EPS Next Est | $-5.19 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRNX | $44.43 | -1.1% | 1.70M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Crinetics Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW